7ql6: Difference between revisions
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Torpedo muscle-type nicotinic acetylcholine receptor - carbamylcholine-bound conformation== | |||
<StructureSection load='7ql6' size='340' side='right'caption='[[7ql6]], [[Resolution|resolution]] 3.23Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[7ql6]] is a 5 chain structure with sequence from [https://en.wikipedia.org/wiki/Tetronarce_californica Tetronarce californica]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7QL6 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7QL6 FirstGlance]. <br> | |||
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Electron Microscopy, [[Resolution|Resolution]] 3.23Å</td></tr> | |||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=CCE:2-[(AMINOCARBONYL)OXY]-N,N,N-TRIMETHYLETHANAMINIUM'>CCE</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7ql6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7ql6 OCA], [https://pdbe.org/7ql6 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7ql6 RCSB], [https://www.ebi.ac.uk/pdbsum/7ql6 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7ql6 ProSAT]</span></td></tr> | |||
</table> | |||
== Function == | |||
[https://www.uniprot.org/uniprot/ACHA_TETCF ACHA_TETCF] After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. | |||
<div style="background-color:#fffaf0;"> | |||
== Publication Abstract from PubMed == | |||
Fast synaptic communication requires receptors that respond to the presence of neurotransmitter by opening an ion channel across the post-synaptic membrane. The muscle-type nicotinic acetylcholine receptor from the electric fish, Torpedo, is the prototypic ligand-gated ion channel, yet the structural changes underlying channel activation remain undefined. Here we use cryo-EM to solve apo and agonist-bound structures of the Torpedo nicotinic receptor embedded in a lipid nanodisc. Using both a direct biochemical assay to define the conformational landscape and molecular dynamics simulations to assay flux through the pore, we correlate structures with functional states and elucidate the motions that lead to pore activation of a heteromeric nicotinic receptor. We highlight an underappreciated role for the complementary subunit in channel gating, establish the structural basis for the differential agonist affinities of alpha/delta versus alpha /gamma sites, and explain why nicotine is less potent at muscle nicotinic receptors compared to neuronal ones. | |||
Conformational transitions and ligand-binding to a muscle-type nicotinic acetylcholine receptor.,Zarkadas E, Pebay-Peyroula E, Thompson MJ, Schoehn G, Uchanski T, Steyaert J, Chipot C, Dehez F, Baenziger JE, Nury H Neuron. 2022 Apr 20;110(8):1358-1370.e5. doi: 10.1016/j.neuron.2022.01.013. Epub , 2022 Feb 8. PMID:35139364<ref>PMID:35139364</ref> | |||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |||
[[Category: | </div> | ||
<div class="pdbe-citations 7ql6" style="background-color:#fffaf0;"></div> | |||
==See Also== | |||
*[[Acetyl choline receptor 3D structures|Acetyl choline receptor 3D structures]] | |||
== References == | |||
<references/> | |||
__TOC__ | |||
</StructureSection> | |||
[[Category: Large Structures]] | |||
[[Category: Tetronarce californica]] | |||
[[Category: Baenziger J]] | |||
[[Category: Nury H]] | |||
[[Category: Pebay-Peyroula E]] | |||
[[Category: Zarkadas E]] | |||
Latest revision as of 16:55, 6 November 2024
Torpedo muscle-type nicotinic acetylcholine receptor - carbamylcholine-bound conformationTorpedo muscle-type nicotinic acetylcholine receptor - carbamylcholine-bound conformation
Structural highlights
FunctionACHA_TETCF After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. Publication Abstract from PubMedFast synaptic communication requires receptors that respond to the presence of neurotransmitter by opening an ion channel across the post-synaptic membrane. The muscle-type nicotinic acetylcholine receptor from the electric fish, Torpedo, is the prototypic ligand-gated ion channel, yet the structural changes underlying channel activation remain undefined. Here we use cryo-EM to solve apo and agonist-bound structures of the Torpedo nicotinic receptor embedded in a lipid nanodisc. Using both a direct biochemical assay to define the conformational landscape and molecular dynamics simulations to assay flux through the pore, we correlate structures with functional states and elucidate the motions that lead to pore activation of a heteromeric nicotinic receptor. We highlight an underappreciated role for the complementary subunit in channel gating, establish the structural basis for the differential agonist affinities of alpha/delta versus alpha /gamma sites, and explain why nicotine is less potent at muscle nicotinic receptors compared to neuronal ones. Conformational transitions and ligand-binding to a muscle-type nicotinic acetylcholine receptor.,Zarkadas E, Pebay-Peyroula E, Thompson MJ, Schoehn G, Uchanski T, Steyaert J, Chipot C, Dehez F, Baenziger JE, Nury H Neuron. 2022 Apr 20;110(8):1358-1370.e5. doi: 10.1016/j.neuron.2022.01.013. Epub , 2022 Feb 8. PMID:35139364[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
| ||||||||||||||||||